80 related articles for article (PubMed ID: 34424575)
1. Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Loscocco GG; Guglielmelli P; Gangat N; Rossi E; Mannarelli C; Betti S; Maccari C; Ramundo F; Jadoon Y; Gesullo F; Ceglie S; Paoli C; Pardanani A; De Stefano V; Tefferi A; Vannucchi AM
Am J Hematol; 2021 Nov; 96(11):1472-1480. PubMed ID: 34424575
[TBL] [Abstract][Full Text] [Related]
2. A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Tefferi A; Loscocco GG; Farrukh F; Szuber N; Mannelli F; Pardanani A; Hanson CA; Ketterling RP; De Stefano V; Carobbio A; Barbui T; Guglielmelli P; Gangat N; Vannucchi AM
Am J Hematol; 2023 Dec; 98(12):1829-1837. PubMed ID: 37665758
[TBL] [Abstract][Full Text] [Related]
3. Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases.
Gangat N; Guglielmelli P; Betti S; Farrukh F; Carobbio A; Barbui T; Vannucchi AM; De Stefano V; Tefferi A
Am J Hematol; 2021 Dec; 96(12):1580-1586. PubMed ID: 34453762
[TBL] [Abstract][Full Text] [Related]
4. Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet.
Alvarez-Larrán A; Sant'Antonio E; Harrison C; Kiladjian JJ; Griesshammer M; Mesa R; Ianotto JC; Palandri F; Hernández-Boluda JC; Birgegård G; Nangalia J; Koschmieder S; Rumi E; Barbui T
Lancet Haematol; 2021 Sep; 8(9):e658-e665. PubMed ID: 34450103
[TBL] [Abstract][Full Text] [Related]
5. Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.
Loscocco GG; Coltro G; Guglielmelli P; Vannucchi AM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440731
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.
Karagianni A; Ravid K
Blood; 2022 May; 139(21):3127-3137. PubMed ID: 34428274
[TBL] [Abstract][Full Text] [Related]
7. Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.
Tefferi A; Vannucchi AM; Barbui T
Leukemia; 2021 Dec; 35(12):3339-3351. PubMed ID: 34480106
[TBL] [Abstract][Full Text] [Related]
8. Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera.
How J; Hobbs G
Curr Hematol Malig Rep; 2021 Oct; 16(5):473-482. PubMed ID: 34478054
[TBL] [Abstract][Full Text] [Related]
9. Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
Gecht J; Tsoukakis I; Kricheldorf K; Stegelmann F; Klausmann M; Griesshammer M; Schulz H; Hollburg W; Göthert JR; Sockel K; Heidel FH; Gattermann N; Maintz C; Al-Ali HK; Platzbecker U; Hansen R; Hänel M; Parmentier S; Bommer M; Pahl HL; Lang F; Kirschner M; Isfort S; Brümmendorf TH; Döhner K; Koschmieder S
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439237
[TBL] [Abstract][Full Text] [Related]
10. Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
Tosetto A; Rocca B; Petrucci G; Betti S; Soldati D; Rossi E; Timillero A; Cavalca V; Porro B; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Priolo S; Randi ML; Bertozzi I; Loscocco GG; Ricco A; Specchia G; Vannucchi AM; Rodeghiero F; De Stefano V; Patrono C;
Clin Pharmacol Ther; 2022 Apr; 111(4):939-949. PubMed ID: 34743317
[TBL] [Abstract][Full Text] [Related]
11. [State-of-the-art management for essential thrombocythemia and polycythemia vera].
Sugimoto Y
Rinsho Ketsueki; 2021; 62(8):1050-1059. PubMed ID: 34497191
[TBL] [Abstract][Full Text] [Related]
12. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities.
Coltro G; Loscocco GG; Vannucchi AM
Int Rev Cell Mol Biol; 2021; 365():1-69. PubMed ID: 34756241
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.
Sekhri R; Sadjadian P; Becker T; Kolatzki V; Huenerbein K; Meixner R; Marchi H; Wallmann R; Fuchs C; Griesshammer M; Wille K
Ann Hematol; 2021 Nov; 100(11):2707-2716. PubMed ID: 34462786
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis.
Komrokji R; Melody M; Al Ali N; Chan O; Klimek V; Ball BJ; Sekeres MA; Lucas G; Maciejewski JP; Sallman DA; Padron E; Kuykendall A; Lasho T; Al-Kali A; Naqvi K; Steensma DP; Garcia-Manero G; Patnaik MM
Leuk Lymphoma; 2022 Jan; 63(1):199-204. PubMed ID: 34448437
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.
Knudsen TA; Skov V; Stevenson K; Werner L; Duke W; Laurore C; Gibson CJ; Nag A; Thorner AR; Wollison B; Hansen DL; Ellervik C; El Fassi D; de Stricker K; Ocias LF; Brabrand M; Bjerrum OW; Overgaard UM; Frederiksen M; Kristensen TK; Kruse TA; Thomassen M; Mourits-Andersen T; Severinsen MT; Stentoft J; Starklint J; Neuberg DS; Kjaer L; Larsen TS; Hasselbalch HC; Lindsley RC; Mullally A
Blood Adv; 2022 Apr; 6(7):2107-2119. PubMed ID: 34507355
[TBL] [Abstract][Full Text] [Related]
16. Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials.
Stein BL
Curr Hematol Malig Rep; 2021 Oct; 16(5):483-489. PubMed ID: 34499329
[TBL] [Abstract][Full Text] [Related]
17. Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms.
Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim I; Yoon SS; Park H; Bang SM
Sci Rep; 2021 Sep; 11(1):17819. PubMed ID: 34497309
[TBL] [Abstract][Full Text] [Related]
18. Myelofibrosis: let's go high!
Ballen K
Bone Marrow Transplant; 2021 Nov; 56(11):2864-2865. PubMed ID: 34446854
[No Abstract] [Full Text] [Related]
19. Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell Lymphoma: A Case Report.
Kameda S; Sera F; Sato K; Kurashige M; Higo S; Ohtani T; Tsuboi A; Hikoso S; Morii E; Yamaguchi O; Yamauchi-Takihara K; Sakata Y
Am J Case Rep; 2021 Aug; 22():e932956. PubMed ID: 34433800
[TBL] [Abstract][Full Text] [Related]
20. T-cell Acute Lymphoblastic Leukemia in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review.
Medawar G; Ackula H; Weinberg O; Roberts T; Meleveedu K
Leuk Res Rep; 2021; 16():100264. PubMed ID: 34430196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
